Mar 20 |
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
|
Mar 11 |
Avid Bioservices Inc (CDMO) Releases Preliminary Q3 Financial Results
|
Mar 8 |
Avid Bioservices Faces Financial Strain Amid Market Challenges (Rating Downgrade)
|
Mar 7 |
Biotech/Pharma Contract Service Provider Avid Bioservices Sees Lower Than Expected Q3 Sales, Sticks To Annual Guidance
|
Mar 7 |
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
Mar 7 |
Avid Bio slumps after Q3 results and convertible debt offering
|
Mar 7 |
Victoria's Secret Posts Weak Sales, Joins ADT, Avid Bioservices And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
|
Mar 7 |
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
|
Mar 6 |
Avid Bioservices says revenues for third quarter of fiscal 2024 were $33.8 million
|
Mar 6 |
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
|